Emanuela Sant’Antonio

4.2k total citations · 1 hit paper
28 papers, 988 citations indexed

About

Emanuela Sant’Antonio is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Emanuela Sant’Antonio has authored 28 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 15 papers in Hematology and 12 papers in Rheumatology. Recurrent topics in Emanuela Sant’Antonio's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (20 papers), Eosinophilic Disorders and Syndromes (12 papers) and Acute Myeloid Leukemia Research (9 papers). Emanuela Sant’Antonio is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (20 papers), Eosinophilic Disorders and Syndromes (12 papers) and Acute Myeloid Leukemia Research (9 papers). Emanuela Sant’Antonio collaborates with scholars based in Italy, United States and France. Emanuela Sant’Antonio's co-authors include Elisa Rumi, Daniela Pietra, Ilaria Carola Casetti, Emanuela Boveri, Mario Cazzola, Virginia Valeria Ferretti, Chiara Milanesi, Cesare Astori, Cristiana Pascutto and Marta Bellini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Emanuela Sant’Antonio

26 papers receiving 974 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

2013 391 citations Elisa Rumi, Daniela Pietra et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emanuela Sant’Antonio Italy	12	858	662	608	323	45	28	988
Yoko Edahiro Japan	11	472 0.6×	356 0.5×	299 0.5×	138 0.4×	44 1.0×	51	593
Nora P. Goette Argentina	14	194 0.2×	334 0.5×	121 0.2×	80 0.2×	62 1.4×	30	485
Jacob Grinfeld United Kingdom	11	277 0.3×	228 0.3×	177 0.3×	112 0.3×	20 0.4×	19	365
Yoshitaka Sunami Japan	10	307 0.4×	263 0.4×	246 0.4×	70 0.2×	41 0.9×	18	449
AA Axelrad Canada	10	348 0.4×	383 0.6×	207 0.3×	75 0.2×	64 1.4×	18	665
D Eskinazi Canada	9	327 0.4×	285 0.4×	159 0.3×	103 0.3×	32 0.7×	16	453
Irini Xilouri Greece	7	119 0.1×	208 0.3×	238 0.4×	26 0.1×	13 0.3×	13	375
DV Faller United States	6	167 0.2×	163 0.2×	235 0.4×	42 0.1×	68 1.5×	7	431
Benoît Guillet France	14	146 0.2×	479 0.7×	110 0.2×	13 0.0×	32 0.7×	46	578
Gabriele Sarais Italy	7	129 0.2×	88 0.1×	466 0.8×	67 0.2×	14 0.3×	7	505

Countries citing papers authored by Emanuela Sant’Antonio

Since Specialization

Citations

This map shows the geographic impact of Emanuela Sant’Antonio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Sant’Antonio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Sant’Antonio more than expected).

Fields of papers citing papers by Emanuela Sant’Antonio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuela Sant’Antonio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Sant’Antonio. The network helps show where Emanuela Sant’Antonio may publish in the future.

Co-authorship network of co-authors of Emanuela Sant’Antonio

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuela Sant’Antonio. A scholar is included among the top collaborators of Emanuela Sant’Antonio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuela Sant’Antonio. Emanuela Sant’Antonio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sant’Antonio, Emanuela, et al.. (2025). Monoclonal B‐Cell Lymphocytosis: The Silent Clone the Haematologists Should Not Neglect. Hematological Oncology. 43(S2). e70084–e70084.

Cencini, Emanuele, Ilaria Romano, Lara Mannelli, et al.. (2023). Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network). Annals of Hematology. 102(4). 841–849. 1 indexed citations

Borsani, Oscar, Paul Bastard, Jérémie Rosain, et al.. (2022). Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms. Blood. 139(17). 2716–2720. 3 indexed citations

Breccia, Massimo, Francesca Palandri, Paola Guglielmelli, et al.. (2022). Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance. Current Oncology. 29(7). 4970–4980. 4 indexed citations

Vanni, Daniele, Oscar Borsani, Yasuhito Nannya, et al.. (2022). Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms. SHILAP Revista de lepidopterología. 3(2). 475–479. 1 indexed citations

Capasso, Antonella, Elisabetta Albi, Francesca Martini, et al.. (2022). CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL. Clinical Lymphoma Myeloma & Leukemia. 22. S279–S280. 2 indexed citations

Irrera, Natasha, et al.. (2021). Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies. Molecules. 26(13). 3866–3866. 7 indexed citations

Álvarez‐Larrán, Alberto, Emanuela Sant’Antonio, Claire Harrison, et al.. (2021). Unmet clinical needs in the management of CALR-mutated essential thrombocythaemia: a consensus-based proposal from the European LeukemiaNet. The Lancet Haematology. 8(9). e658–e665. 17 indexed citations

Sant’Antonio, Emanuela, et al.. (2021). Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence Prognosis, Treatment Outcome, and Risk of Cardiovascular Events. Clinical Lymphoma Myeloma & Leukemia. 21(9). 573–579. 6 indexed citations

10.

Sant’Antonio, Emanuela, Oscar Borsani, Cirino Botta, et al.. (2021). Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy. Blood Reviews. 52. 100903–100903. 3 indexed citations

11.

Sant’Antonio, Emanuela, et al.. (2021). Unusual presentation of extranodal diffuse large B-cell lymphoma in a solid-organ recipient during long-term immunosuppressive treatment. Tumori Journal. 107(6). NP127–NP130.

12.

Coltro, Giacomo, Giada Rotunno, Lara Mannelli, et al.. (2020). RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features. Blood Advances. 4(15). 3677–3687. 52 indexed citations

13.

Rumi, Elisa, Emanuela Sant’Antonio, Chiara Cavalloni, et al.. (2020). Impaired virus‐specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib. Hematological Oncology. 38(4). 554–559. 4 indexed citations

14.

Breccia, Massimo, Claudia Baratè, Giulia Benevolo, et al.. (2019). Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice. Annals of Hematology. 99(1). 65–72. 11 indexed citations

15.

Sant’Antonio, Emanuela, Massimiliano Bonifacio, Massimo Breccia, & Elisa Rumi. (2019). A journey through infectious risk associated with ruxolitinib. British Journal of Haematology. 187(3). 286–295. 24 indexed citations

16.

Rumi, Elisa, Emanuela Sant’Antonio, Emanuela Boveri, et al.. (2018). Diagnosis and management of prefibrotic myelofibrosis. Expert Review of Hematology. 11(7). 537–545. 12 indexed citations

17.

Pietra, Daniela, Elisa Rumi, Virginia Valeria Ferretti, et al.. (2015). Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms. Leukemia. 30(2). 431–438. 178 indexed citations

18.

Rumi, Elisa, Daniela Pietra, Virginia Valeria Ferretti, et al.. (2013). JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood. 123(10). 1544–1551. 391 indexed citations breakdown →

19.

Allegra, Alessandro, Emanuela Sant’Antonio, Giuseppa Penna, et al.. (2010). Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors. European Journal Of Haematology. 86(2). 93–110. 43 indexed citations

20.

Musolino, Caterina, Emanuela Sant’Antonio, Giuseppa Penna, et al.. (2010). Epigenetic therapy in myelodysplastic syndromes. European Journal Of Haematology. 84(6). 463–473. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact